This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...
CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR ...
This review examines how CAR-T cell therapy is expanding beyond blood cancers into solid tumors, autoimmune diseases, chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results